Symbiosis Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Naraingarh, Haryana, India, established in 2003.
2003 Naraingarh, Haryana, India Active
Last Updated:
Access Report
About Symbiosis Pharmaceuticals Private Limited

Symbiosis Pharmaceuticals Private Limited, a active private limited company, was established on 04 April 2003 in Naraingarh, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239HR2003PTC035085. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹7.93 Cr.

Formerly known as Symbiosis Pharmaceutical Private Limited. It upholds a compliant status. Employing 47 professional, Its leadership includes Harnek Singh (Director), Jagbir Singh (Director), Sheetal Dass (Director). Past directors included Hukam Malik Chand, Jagbir Singh, Vishwambhar Dayal Gupta. It holds ₹65.89 Cr open charges and ₹12.37 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House Number 341, Sector 4, Urban Estate,, Naraingarh, Haryana, 134203.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239HR2003PTC035085

  • Registration Number

    035085

  • Incorporation Date

    04 April 2003

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹7.93 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 7.93 Cr
  • Company Age 22 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 65.89 Cr
  • Satisfied Charges ₹ 12.37 Cr
  • Revenue Growth **** -18.61%
  • Profit Growth **** 0.17%
  • Ebitda **** 0.26%
  • Net Worth 6.44%
  • Total Assets **** 4.40%
Company report

Symbiosis Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Symbiosis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Symbiosis Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Harnek Singh Director 12 Apr 2021 Current
Jagbir Singh Director 04 Apr 2003 Current
Sheetal Dass Director 30 Jun 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Feb 2007 Past
Pramod Abcsdd Managing Director 01 May 2017 Past
Pramod Abcsdd Director 15 Mar 2025 Past
Pramod Abcsdd Director 01 Oct 2008 Past
Pramod Abcsdd Manager 31 Dec 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Symbiosis Pharmaceuticals.

Symbiosis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.61% decrease. The company also saw a slight improvement in profitability, with a 0.17% increase in profit. The company's net worth moved up by a moderate rise of 6.44%.

Symbiosis Pharmaceuticals revenue growth over time
Symbiosis Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -18.61%
*******
*******
*******
*******
Revenue from Operations
*******
 -18.70%
*******
*******
*******
*******
Total Assets
*******
 4.40%
*******
*******
*******
*******
Profit or Loss
*******
 0.17%
*******
*******
*******
*******
Net Worth
*******
 6.44%
*******
*******
*******
*******
EBITDA
*******
 0.26%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Symbiosis Pharmaceuticals?

In 2023, Symbiosis Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹658,937,834.00

Satisfied Charges

₹123,652,059.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 60.80 Cr
  • Sidbi : 4.26 Cr
  • General Manager : 0.30 Cr
  • Hdfc Bank Limited : 0.28 Cr
  • Others : 0.25 Cr
Latest Charge Details
Date Lender Amount Status
16 Sep 2025 Sidbi ₹4.55 M Open
12 Jun 2025 State Bank Of India ₹5.60 M Open
17 Mar 2025 Sidbi ₹4.00 M Open
28 Feb 2025 Sidbi ₹2.06 Cr Open
08 Jan 2025 Sidbi ₹1.35 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Symbiosis Pharmaceuticals?

Symbiosis Pharmaceuticals has a workforce of 47 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Symbiosis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiosis Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Symbiosis Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Sidbi amounted to Rs. 0.46 Cr with Charge ID 101167623 was registered on 16 Sep 2025. was completed.

  • Charges

    A charge with State Bank Of India amounted to Rs. 0.56 Cr with Charge ID 101111661 was registered on 12 Jun 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Sidbi amounted to Rs. 0.40 Cr with Charge ID 101087329 was registered on 17 Mar 2025. was completed.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 2.06 Cr with Charge ID 101083710 was registered on 28 Feb 2025. was documented.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 1.35 Cr with Charge ID 101037440 was registered on 08 Jan 2025. was documented.

  • Charges

    Progress on A charge registered on 29 Apr 2019 via Charge ID 100271168 with Hdfc Bank Limited was fully satisfied on 22 Nov 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Symbiosis Pharmaceuticals Private Limited?

The CIN of Symbiosis Pharmaceuticals Private Limited is U24239HR2003PTC035085.

Where is Symbiosis Pharmaceuticals Private Limited headquartered?

Symbiosis Pharmaceuticals Private Limited is headquartered at House Number 341, Sector 4, Urban Estate,, Naraingarh, Haryana, 134203.

When was Symbiosis Pharmaceuticals Private Limited incorporated?

Symbiosis Pharmaceuticals Private Limited was incorporated on 04 April 2003.

Who are the current directors of Symbiosis Pharmaceuticals Private Limited?

The current directors of Symbiosis Pharmaceuticals Private Limited are

What is the primary industry of Symbiosis Pharmaceuticals Private Limited?

The primary industry of Symbiosis Pharmaceuticals Private Limited is Manufacturing.

Is Symbiosis Pharmaceuticals Private Limited a listed company?

Symbiosis Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Symbiosis Pharmaceuticals Private Limited?

The authorized capital of Symbiosis Pharmaceuticals Private Limited is ₹10.00 Cr, and the paid-up capital is ₹7.93 Cr.

What is the compliance status of Symbiosis Pharmaceuticals Private Limited?

The compliance status of Symbiosis Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available